IRS1(胰岛素受体底物1)是一种关键的信号转导蛋白,属于胰岛素受体底物(IRS)家族,该家族还包括IRS2、IRS3和IRS4等成员。IRS家族蛋白的共同特点是它们作为胰岛素和胰岛素样生长因子(IGF-1)受体下游的适配器分子,通过激活PI3K-AKT和MAPK等信号通路调控细胞代谢、生长和存活。IRS1主要在胰岛素敏感组织(如肌肉、脂肪和肝脏)中表达,其核心功能是介导胰岛素信号传导,促进葡萄糖摄取、糖原合成和蛋白质合成,同时抑制糖异生和脂肪分解。IRS1的酪氨酸磷酸化位点(如Y612和Y632)对激活下游信号至关重要,而丝氨酸/苏氨酸磷酸化(如S307)则可能负反馈抑制其活性。IRS1突变或表达异常与多种代谢疾病密切相关,例如2型糖尿病和胰岛素抵抗。某些突变(如G972R)会削弱IRS1与胰岛素受体的结合能力或降低其稳定性,导致信号传导障碍。此外,IRS1多态性(如rs2943641)与心血管疾病和某些癌症风险相关。在过表达情况下,IRS1可能增强胰岛素敏感性,但长期过度激活可能诱发低血糖或促进肿瘤细胞增殖(如乳腺癌和结肠癌)。相反,IRS1表达降低或功能缺失会导致胰岛素抵抗、高血糖和代偿性高胰岛素血症,并可能加速β细胞衰竭。IRS1还与其他基因相互作用,例如其表达受FOXO1调控,而它又能抑制GSK3β活性以调节糖代谢。在脂肪组织中,IRS1缺失会减少脂质储存并增加游离脂肪酸释放,加剧肝脏胰岛素抵抗。值得注意的是,IRS1在衰老过程中表达下降,可能与年龄相关代谢紊乱有关。研究还发现IRS1通过mTOR通路调控自噬,其异常表达可能影响神经退行性疾病进程。IRS家族成员功能既有重叠也有分化,例如IRS2更多参与β细胞存活和中枢胰岛素作用,而IRS1对外周胰岛素敏感性更为关键。
This gene encodes a protein which is phosphorylated by insulin receptor tyrosine kinase. Mutations in this gene are associated with type II diabetes and susceptibility to insulin resistance. [provided by RefSeq, Nov 2009]
该基因编码由胰岛素受体酪氨酸激酶磷酸化的蛋白。在这种基因突变与II型糖尿病和易感性的胰岛素抗性相关。 [由RefSeq的,2009年11月提供]
IRS1基因(以及对应的蛋白质)的细胞分布位置:
IRS1基因的本体(GO)信息:
| 名称 |
|---|
| 4068 FoxO signaling pathway [PATH:hsa04068] |
| 4022 cGMP - PKG signaling pathway [PATH:hsa04022] |
| 4151 PI3K-Akt signaling pathway [PATH:hsa04151] |
| 4152 AMPK signaling pathway [PATH:hsa04152] |
| 4150 mTOR signaling pathway [PATH:hsa04150] |
| 4910 Insulin signaling pathway [PATH:hsa04910] |
| 4920 Adipocytokine signaling pathway [PATH:hsa04920] |
| 4960 Aldosterone-regulated sodium reabsorption [PATH:hsa04960] |
| 4722 Neurotrophin signaling pathway [PATH:hsa04722] |
| 5206 MicroRNAs in cancer [PATH:hsa05206] |
| 4930 Type II diabetes mellitus [PATH:hsa04930] |
| 4932 Non-alcoholic fatty liver disease (NAFLD) [PATH:hsa04932] |
| 名称 |
|---|
| Adaptive Immune System |
| Constitutive Signaling by Aberrant PI3K in Cancer |
| Cytokine Signaling in Immune system |
| DAP12 interactions |
| DAP12 signaling |
| Disease |
| Diseases of signal transduction |
| Downstream signal transduction |
| Downstream signaling events of B Cell Receptor (BCR) |
| Downstream signaling of activated FGFR1 |
| Downstream signaling of activated FGFR2 |
| Downstream signaling of activated FGFR3 |
| Downstream signaling of activated FGFR4 |
| Fc epsilon receptor (FCERI) signaling |
| GAB1 signalosome |
| Growth hormone receptor signaling |
| IGF1R signaling cascade |
| Immune System |
| Innate Immune System |
| Insulin receptor signalling cascade |
| IRS activation |
| IRS-mediated signalling |
| IRS-related events |
| IRS-related events triggered by IGF1R |
| NGF signalling via TRKA from the plasma membrane |
| PI-3K cascade:FGFR1 |
| PI-3K cascade:FGFR2 |
| PI-3K cascade:FGFR3 |
| PI-3K cascade:FGFR4 |
| PI3K Cascade |
| PI3K events in ERBB2 signaling |
| PI3K events in ERBB4 signaling |
| PI3K/AKT activation |
| PI3K/AKT Signaling in Cancer |
| PIP3 activates AKT signaling |
| Role of LAT2/NTAL/LAB on calcium mobilization |
| Signal attenuation |
| Signal Transduction |
| Signaling by EGFR |
| Signaling by ERBB2 |
| Signaling by ERBB4 |
| Signaling by FGFR |
| Signaling by FGFR1 |
| Signaling by FGFR2 |
| Signaling by FGFR3 |
| Signaling by FGFR4 |
| Signaling by Insulin receptor |
| Signaling by Leptin |
| Signaling by PDGF |
| Signaling by SCF-KIT |
| Signaling by the B Cell Receptor (BCR) |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) |
| Signalling by NGF |
| SOS-mediated signalling |
| 疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
| Diabetes Mellitus, Non-Insulin-Dependent | 0.627144187 | 115 | 12 | BeFree_CLINVAR_CTD_human_GAD_MGD_RGD_UNIPROT |
| Obesity | 0.21842571 | 38 | 2 | BeFree_CTD_human_GAD_RGD |
| Diabetes Mellitus, Experimental | 0.2 | 3 | 0 | CTD_human_RGD |
| Insulin Resistance | 0.141303288 | 10 | 0 | CTD_human_GAD |
| Diabetes Mellitus | 0.128610195 | 24 | 3 | BeFree_CTD_human_GAD |
| Coronary Artery Disease | 0.126634157 | 9 | 4 | BeFree_CTD_human_GAD |
| Prostatic Neoplasms | 0.1254487 | 2 | 0 | CTD_human_LHGDN |
| Liver carcinoma | 0.123257302 | 13 | 0 | BeFree_CTD_human |
| Hyperinsulinism | 0.122171535 | 8 | 0 | BeFree_CTD_human |
| INSULIN RESISTANCE, SUSCEPTIBILITY TO | 0.12 | 0 | 1 | CLINVAR |
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269